Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents - PubMed (original) (raw)
. 2005 Dec;115(12):3587-93.
doi: 10.1172/JCI25151. Epub 2005 Nov 10.
Kitt Falk Petersen, Sylvie Dufour, Douglas Befroy, Jared Frattini, Nadine Shatzkes, Susanne Neschen, Morris F White, Stefan Bilz, Saki Sono, Marc Pypaert, Gerald I Shulman
Affiliations
- PMID: 16284649
- PMCID: PMC1280967
- DOI: 10.1172/JCI25151
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
Katsutaro Morino et al. J Clin Invest. 2005 Dec.
Abstract
To further explore the nature of the mitochondrial dysfunction and insulin resistance that occur in the muscle of young, lean, normoglycemic, insulin-resistant offspring of parents with type 2 diabetes (IR offspring), we measured mitochondrial content by electron microscopy and insulin signaling in muscle biopsy samples obtained from these individuals before and during a hyperinsulinemic-euglycemic clamp. The rate of insulin-stimulated muscle glucose uptake was approximately 60% lower in the IR offspring than the control subjects and was associated with an approximately 60% increase in the intramyocellular lipid content as assessed by H magnetic resonance spectroscopy. Muscle mitochondrial density was 38% lower in the IR offspring. These changes were associated with a 50% increase in IRS-1 Ser312 and IRS-1 Ser636 phosphorylation and an approximately 60% reduction in insulin-stimulated Akt activation in the IR offspring. These data provide new insights into the earliest defects that may be responsible for the development of type 2 diabetes and support the hypothesis that reductions in mitochondrial content result in decreased mitochondrial function, which predisposes IR offspring to intramyocellular lipid accumulation, which in turn activates a serine kinase cascade that leads to defects in insulin signaling and action in muscle.
Figures
Figure 1
Results of oral glucose tolerance test. Mean plasma concentrations of glucose (A) and insulin (B) before and during a 75-g oral glucose tolerance test in control subjects (n = 6) and IR offspring (n = 8). P = 0.0009 for the comparison of the areas under the curve for insulin concentration of control subjects and IR offspring.
Figure 2
Hyperinsulinemic-euglycemic clamp and intramyocellular lipid content. (A) Insulin-stimulated rates of muscle glucose metabolism in control subjects (n = 6) and IR offspring (n = 8). (B) Intramyocellular lipid content in soleus muscle of control subjects (n = 6) and IR offspring (n = 8), measured by localized 1H MRS.
Figure 3
Mitochondrial density and gene expression data. (A) Mitochondrial density in control subjects (n = 6) and IR offspring (n = 8), assessed by electron microscopy. The pound symbol (#) indicates muscle fiber; the asterisk indicates mitochondrion. (B) Mitochondrial protein expressions assessed by Western blotting in control subjects (n = 6) and IR offspring (n = 9). Results were normalized to β-actin protein expression. SDH, succinate dehydrogenase; PDH, pyruvate dehydrogenase.
Figure 4
mRNA and protein expression of mitochondrial biogenesis genes. (A) mRNA expression of PGC-1 and downstream genes determined by real-time quantitative PCR using a TaqMan probe in control subjects (n = 7) and IR offspring (n = 13). (B) Protein expression of PGC-1α, PGC-1β, and mtTFA measured by Western blotting in control subjects (n = 6) and IR offspring (n = 9). (C) mtDNA copy number was determined by real-time quantitative PCR using a TaqMan probe against NADH dehydrogenase 2 (ND2) and β-actin. mtDNA copy number was calculated as the ratio of ND2 to β-actin in control subjects (n = 7) and IR offspring (n = 9).
Figure 5
Insulin signaling data. (A) IRS-1 serine phosphorylation at Ser307, Ser312, Ser616, and Ser636 in the basal state in control subjects (n = 10) and IR offspring (n = 7). (B) Insulin-stimulated Akt phosphorylation at 20 minutes on Ser473 in control subjects (n = 5) and IR offspring (n = 7). Akt phosphorylation was normalized to total Akt protein expression.
Similar articles
- Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
Petersen KF, Dufour S, Shulman GI. Petersen KF, et al. PLoS Med. 2005 Sep;2(9):e233. doi: 10.1371/journal.pmed.0020233. Epub 2005 Aug 16. PLoS Med. 2005. PMID: 16089501 Free PMC article. Clinical Trial. - Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].
Storgaard H, Song XM, Jensen CB, Madsbad S, Björnholm M, Vaag A, Zierath JR. Storgaard H, et al. Diabetes. 2001 Dec;50(12):2770-8. doi: 10.2337/diabetes.50.12.2770. Diabetes. 2001. PMID: 11723060 - Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Petersen KF, et al. N Engl J Med. 2004 Feb 12;350(7):664-71. doi: 10.1056/NEJMoa031314. N Engl J Med. 2004. PMID: 14960743 Free PMC article. - Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
Morino K, Petersen KF, Shulman GI. Morino K, et al. Diabetes. 2006 Dec;55 Suppl 2(Suppl 2):S9-S15. doi: 10.2337/db06-S002. Diabetes. 2006. PMID: 17130651 Free PMC article. Review. - Etiology of insulin resistance.
Petersen KF, Shulman GI. Petersen KF, et al. Am J Med. 2006 May;119(5 Suppl 1):S10-6. doi: 10.1016/j.amjmed.2006.01.009. Am J Med. 2006. PMID: 16563942 Free PMC article. Review.
Cited by
- Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson's Disease.
Salis Torres A, Lee JE, Caporali A, Semple RK, Horrocks MH, MacRae VE. Salis Torres A, et al. Int J Mol Sci. 2024 Oct 12;25(20):10973. doi: 10.3390/ijms252010973. Int J Mol Sci. 2024. PMID: 39456761 Free PMC article. Review. - 1,2-Dicinnamoyl-_sn_-glycero-3-phosphocholine Improves Insulin Sensitivity and Upregulates mtDNA-Encoded Genes in Insulin-Resistant 3T3-L1 Adipocytes: A Preliminary Study.
Cierzniak A, Gliszczyńska A, Małodobra-Mazur M. Cierzniak A, et al. Nutrients. 2024 Sep 19;16(18):3163. doi: 10.3390/nu16183163. Nutrients. 2024. PMID: 39339765 Free PMC article. - Aging delays the suppression of lipolysis and fatty acid oxidation in the postprandial period.
Osmond AD, Leija RG, Arevalo JA, Curl CC, Duong JJ, Huie MJ, Masharani U, Brooks GA. Osmond AD, et al. J Appl Physiol (1985). 2024 Nov 1;137(5):1200-1219. doi: 10.1152/japplphysiol.00437.2024. Epub 2024 Sep 5. J Appl Physiol (1985). 2024. PMID: 39236144 - Cytosolic calcium regulates hepatic mitochondrial oxidation, intrahepatic lipolysis, and gluconeogenesis via CAMKII activation.
LaMoia TE, Hubbard BT, Guerra MT, Nasiri A, Sakuma I, Kahn M, Zhang D, Goodman RP, Nathanson MH, Sancak Y, Perelis M, Mootha VK, Shulman GI. LaMoia TE, et al. Cell Metab. 2024 Oct 1;36(10):2329-2340.e4. doi: 10.1016/j.cmet.2024.07.016. Epub 2024 Aug 16. Cell Metab. 2024. PMID: 39153480 - P38α MAPK Coordinates Mitochondrial Adaptation to Caloric Surplus in Skeletal Muscle.
Waingerten-Kedem L, Aviram S, Blau A, Hayek T, Bengal E. Waingerten-Kedem L, et al. Int J Mol Sci. 2024 Jul 16;25(14):7789. doi: 10.3390/ijms25147789. Int J Mol Sci. 2024. PMID: 39063031 Free PMC article.
References
- Griffin ME, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 1999;48:1270–1274. - PubMed
- Yu C, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002;277:50230–50236. - PubMed
- Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002;51:2005–2011. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK049230/DK/NIDDK NIH HHS/United States
- P01 DK068229/DK/NIDDK NIH HHS/United States
- P30 DK-45735/DK/NIDDK NIH HHS/United States
- R01 DK-063192/DK/NIDDK NIH HHS/United States
- R01 DK040936/DK/NIDDK NIH HHS/United States
- R01 AG023686/AG/NIA NIH HHS/United States
- P30 DK045735/DK/NIDDK NIH HHS/United States
- R01 DK-49230/DK/NIDDK NIH HHS/United States
- M01 RR-00125/RR/NCRR NIH HHS/United States
- P01 DK-68229/DK/NIDDK NIH HHS/United States
- R01 AG-23686/AG/NIA NIH HHS/United States
- M01 RR000125/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases